Related Experiment Video

Updated: Jun 6, 2026

Isolation of Functional Cardiac Immune Cells
07:26

Isolation of Functional Cardiac Immune Cells

Published on: December 5, 2011

Inflammatory reactions and hydrocortisone in the setting of cardiac surgery: an overview

Jens Heyn1, Andres Beiras-Fernandez, Benjamin Luchting

  • 1Department of Anaesthesiology-Grosshadern, University Hospital Munich, Marchioninistrasse 15, 81377 Munich, Germany.

Cardiovascular & Hematological Agents in Medicinal Chemistry
|November 12, 2010
PubMed

Insights

Corticosteroids like hydrocortisone may mitigate systemic inflammation after cardiac surgery with cardiopulmonary bypass (CPB). However, current evidence is conflicting, necessitating further research on their risks and benefits in cardiac surgery patients.

Area of Science:

  • Cardiology
  • Immunology
  • Pharmacology

Background:

  • Cardiac surgery with cardiopulmonary bypass (CPB) triggers a systemic inflammatory response.
  • This inflammation can lead to post-operative complications like reduced cardiac function and multi-organ dysfunction.
  • Corticosteroids are used for their anti-inflammatory properties in critical care.

Purpose of the Study:

  • To review existing data on the use of hydrocortisone in cardiac surgery.
  • To evaluate the risks, benefits, contraindications, and adverse effects of hydrocortisone prophylaxis.
  • To assess the current evidence for hydrocortisone in CPB patients.

Main Methods:

  • Review of studies on corticosteroid use in cardiac surgery.
  • Analysis of data concerning hydrocortisone, methylprednisolone, and their effects.
  • Examination of clinical outcomes and inflammatory markers.

Main Results:

  • Conflicting results exist for methylprednisolone and hydrocortisone prophylaxis.
  • Hydrocortisone is a standard treatment for sepsis but has limited study data in cardiac surgery.
  • CPB-induced inflammation remains a significant post-operative concern.

Conclusions:

  • Further research is needed to clarify the role of hydrocortisone in cardiac surgery.
  • Balancing the anti-inflammatory benefits against potential risks is crucial.
  • Increased studies on hydrocortisone are anticipated in the coming years.

More Related Videos

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...